All In Biotech

Drug Trial Radar · NCT05486416

Safety and Efficacy of HSK3486 Compared to Propofol for Induction of General Anesthesia in Adults With Elective Surgery

A Global Multicenter, Randomized, Double-blinded, Propofol-controlled, Phase 3 Clinical Study to Evaluate the Efficacy and Safety of HSK3486 Injectable Emulsion for Induction of General Anesthesia in Adults Undergoing Elective Surgery

Last checked: Nov 19, 2026Latest source record: Oct 10, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 465 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

465

Actual

Start

Jan 12, 2024

Primary completion

Jul 23, 2024

Study completion Jul 23, 2024

Sponsor

Sponsor type
Industry
First posted
Aug 3, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Single (participant)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 99 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

To demonstrate HSK3486 0.4/0.2 mg/kg (0.4 mg/kg intravenous \[IV\] slow injection over 30 \[±5\] seconds for the first dose, an additional 0.2 mg/kg if needed) is non-inferior to Propofol 2.0/1.0 mg/kg (2.0 mg/kg IV slow injection over 30 \[±5\] seconds for first dose, an additional 1.0 mg/kg if needed) in success of induction of general anesthesia in adults undergoing elective surgery.

Conditions

  • General Anesthesia

Interventions

  • HSK3486Drug

    HSK3486 for induction of general anesthesia

  • PropofolDrug

    Propofol for induction of general anesthesia

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Success Rate of General Anesthesia InductionTime frame: From the time of study drug administration to desired depth of anesthesia to MOAA/S≤1( up to 5 minutes)

Locations

28 sites in 3 countries. Site status is shown where the registry gives one.

  • North Alabama Medical Center

    Florence, Alabama

  • Helen Keller Hospital

    Sheffield, Alabama

  • University of Miami Hospital

    Miami, Florida

  • Gulfcoast Research Institute

    Sarasota, Florida

  • Phoenix Clinical Research, LLC

    Tamarac, Florida

  • ForCare Clinical Research

    Tampa, Florida

  • Atlanta Center for Medical Research

    Atlanta, Georgia

  • EBGS Clinical Research Center

    Snellville, Georgia

  • University of Iowa Hospitals and Clinics (Dept of Anesthesia)

    Iowa City, Iowa

  • U of L Health, University of Louisville Hospital

    Louisville, Kentucky

  • The Brigham and Women's Hospital

    Boston, Massachusetts

  • Michigan Medicine

    Ann Arbor, Michigan

  • M3-Emerging Medical Research, LLC

    Durham, North Carolina

  • Duke University Medical Center (DUMC)

    Durham, North Carolina

  • The Ohio State University Wexner Medical Center - University Hospital

    Columbus, Ohio

  • First Surgical Hospital

    Bellaire, Texas

  • Legent Orthopedic Hospital

    Carrollton, Texas

  • The University of Texas MD Anderson Cancer Center

    Houston, Texas

  • Memorial Hermann Village

    Houston, Texas

  • Clinical Trials of Texas, LLC

    San Antonio, Texas

  • Endeavor Clinical Trials, LLC

    San Antonio, Texas

  • Uniwersytecki Szpital Kliniczny W Opolu

    Opole, Poland

  • Państwowy Instytut Medyczny Mswia - Klinika Anestezjologii I Intensywnej Terapii

    Warsaw, Poland

  • Spsk Nr 1 Im. Prof. S. Szyszko

    Zabrze, Poland

  • Hospital Clinic De Barcelona

    Barcelona, Spain

  • Hospital General Universitario De Ciudad Real

    Ciudad Real, Spain

  • Universidad de Navarra - Clinica Universidad de Navarra en Pamplona

    Pamplona, Spain

  • Hospital Clinico Universitario de Valencia (CHUV)

    Valencia, Spain

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.